Lexeo Therapeutics, Inc. (LXEO)

SEC filing

Lexeo Therapeutics, Inc.

LXEO · CIK 1907108

4 · Sep 28, 2026 · Director, Chief Executive Officer Townsend Richard Nolan was granted 147.81K shares at $0.0413/share ($6,097)

Director, Chief Executive Officer Townsend Richard Nolan was granted 147.81K shares at $0.0413/share ($6,097)

xslF345X06/form4-09282026_050901.xml

xslF345X06/form4-09282026_050901.xmlSEC.gov

Graphics and non-inline formats (not embedded below).